The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...

JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...

A new class of South Korean immunotherapy drugs is raising hopes for a breakthrough in the treatment of a rare blood cancer ...

Clozapine blood monitoring can now be reduced to every 12 weeks after 1 year of treatment, and annually after 2 years, in patients without neutropenia.

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE ...

On July 3, Janssen-Cilag, a company of Johnson & Johnson (NYSE:JNJ), reported applying to the European Medicines Agency to ...

People of a certain age may remember Merthiolate and Mercurochrome in the household medicine chest. Whenever someone skinned ...

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...

Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...